Apollo Hospital, Chennai introduces the first digital PET/CT – Biograph Vision
Biograph Vision is designed for improved accuracy, performance, and reproducibility to deliver a whole new world of precision in PET/CT imaging
With nearly a million new cancer cases diagnosed per annum in India, staging disease more accurately and defining treatment strategies better is the need of the hour. With the introduction of Biograph Vision™ in India, addressing cancer progression with personalized medicine will help deliver the right treatment to the right patient and at the right time.
PET/CT is indispensable as a diagnostic and prognostic tool in the assessment of patient response to cancer therapy and cancer recurrence. The Biograph Vision™ from Siemens Healthineers enables a better understanding of disease progression and treatment resistance, to define treatments that can be precisely tailored for patients.
“Biograph Vision is designed for improved accuracy, performance, and reproducibility to deliver a whole new world of precision in PET/CT imaging. With the market’s fastest time-of-flight and highest effective sensitivity, Biograph Vision™ helps reduce scan time and injected dose, reducing patient exposure to radiation. With the introduction of Biograph Vision™ Siemens Healthineers is helping Apollo Proton Cancer Centre in Chennai to enhance the quality of patient care and expand precison medicine,” said Vivek Kanade, Executive Director, Siemens Healthineers, India.
Dr Prathap C Reddy, Chairman, Apollo Hospitals Group said, “Our patient centric ethos has always motivated us to invest in the best available for our patients and Apollo has been at the forefront of introducing cutting edge technologies in India and the region. Apollo Proton Cancer Centre in Chennai has ushered new hope for over 3.5 billion people, who earlier would have had to travel to the western world to access Proton Therapy, the world’s most advanced radiation therapy. Increasingly Proton Therapy is becoming the standard of care for several cancers and its unique edge of minimal side effects is transforming quality of cancer survivorship.”